David Tepper Boston Scientific Corp Transaction History

Appaloosa LP

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 16, 2021	SELL	$33.15 - $41.97 $26.1 Million - $33.1 Million	-787,500 Closed	0 $0
Q3 2020 Nov 16, 2020	SELL	$34.44 - $42.23 $5.6 Million - $6.86 Million	-162,500 Reduced 17.11%	787,500 $30.1 Million
Q2 2020 Aug 14, 2020	BUY	$30.19 - $39.11 $25.2 Million - $32.7 Million	835,000 Added 726.09%	950,000 $33.4 Million
Q1 2020 May 15, 2020	BUY	$25.83 - $45.71 $2.97 Million - $5.26 Million	115,000 New	115,000 $3.75 Million
Q4 2018 Feb 14, 2019	SELL	$31.73 - $39.04 $27.1 Million - $33.3 Million	-853,875 Closed	0 $0
Q3 2018 Nov 14, 2018	SELL	$32.83 - $38.63 $55 Million - $64.7 Million	-1,674,263 Reduced 66.23%	853,875 $32.9 Million
Q2 2018 Aug 14, 2018	SELL	$26.84 - $34.32 $37.1 Million - $47.5 Million	-1,382,600 Reduced 35.35%	2,528,138 $82.7 Million
Q1 2018 May 15, 2018	SELL	$25.2 - $28.54 $22 Million - $24.9 Million	-871,945 Reduced 18.23%	3,910,738 $107 Million
Q4 2017 Feb 14, 2018	BUY	$24.79 - $29.8 $25.5 Million - $30.7 Million	1,029,817 Added 27.44%	4,782,683 $119 Million
Q3 2017 Nov 14, 2017	BUY	$26.26 - $29.17 $98.6 Million - $109 Million	3,752,866	3,752,866 $109 Million

1,539

1.19B

6.79M

10.1M

Ticker BSX
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,431,609,984
Market Cap $129B
Description
Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...

Get notified when there are updates to the investment portfolio of Appaloosa LP, based on Form 13F filings with the SEC.

Stay updated on Appaloosa LP and David Tepper with notifications on news.